Replies to post #65156 on Elite Pharmaceuticals Inc (ELTP)

[Drugdoctor]

There was a milestone payment, it was said in the conference call

[Jimmy Joe]

And the reason revenues were not as high as expected is that they ran through their DEA quota for Hydomorphone and Methadone API. Now they have a backlog. And since the then they resumed their quota they resumed production of those products in the first week of July and are playing catch up with that backlog.

As an aside Nasrat did say that the $1.5 million per Quarter or whatever they make for any quarter is not the important thing right now. The cream of the crop is what they want to get to market (all of this paraphrased).

Milestones were included for phentermine launches.